Avaii Wealth Management, LLC Merck & Co., Inc. Transaction History

Avaii Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$123.8 - $132.96 $10,399 - $11,168	-84 Reduced 3.21%	2,529 $313,000
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $33,292 - $38,793	-294 Reduced 10.11%	2,613 $344,000
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $88,258 - $96,046	881 Added 43.48%	2,907 $316,000
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $26,149 - $29,039	-254 Reduced 11.14%	2,026 $208,000
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $10,643 - $11,601	-98 Reduced 4.12%	2,280 $263,000
Q1 2023 Apr 10, 2023	SELL	$102.94 - $114.86 $720 - $804	-7 Reduced 0.29%	2,378 $252,000
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $208,544 - $267,382	2,385 New	2,385 $0

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Avaii Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Avaii Wealth Management, LLC with notifications on news.